{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34258301", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "27"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "06", "Day": "24"}], "Language": ["eng"], "ELocationID": ["9920416", "10.1155/2021/9920416"], "Journal": {"ISSN": "2314-7156", "JournalIssue": {"Volume": "2021", "PubDate": {"Year": "2021"}}, "Title": "Journal of immunology research", "ISOAbbreviation": "J Immunol Res"}, "ArticleTitle": "Natural Formulations: Novel Viewpoint for Scleroderma Adjunct Treatment.", "Pagination": {"StartPage": "9920416", "MedlinePgn": "9920416"}, "Abstract": {"AbstractText": ["Scleroderma is a complex disease involving autoimmune, vascular, and connective tissues, with unknown etiology that can progress through any organ systems.", "Yet, no cure is available; the thorough treatment of scleroderma and current treatments are based on controlling inflammation. Nowadays, medicinal plants/natural-based formulations are emerging as important regulators of many diseases, including autoimmune diseases. Here, we provided an overview of scleroderma, also focused on recent studies on medicinal plants/natural-based formulations that are beneficial in scleroderma treatment/prevention.", "This study is the result of a search in PubMed, Scopus, and Cochrane Library with \"scleroderma\", \"systemic sclerosis\", \"plant\", \"herb\", and \"phytochemical\" keywords. Finally, 22 articles were selected from a total of 1513 results entered in this study.", "Natural products can modulate the inflammatory and/or oxidative mediators, regulate the production or function of the immune cells, and control the collagen synthesis, thereby attenuating the experimental and clinical manifestation of the disease.", "Natural compounds can be considered an adjunct treatment for scleroderma to improve the quality of life of patients suffering from this disease."], "CopyrightInformation": "Copyright \u00a9 2021 Shirin Assar et al."}, "AuthorList": [{"Identifier": ["0000-0002-7278-492X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran."}], "LastName": "Assar", "ForeName": "Shirin", "Initials": "S"}, {"Identifier": ["0000-0002-1058-7613"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6734667149, Iran."}], "LastName": "Khazaei", "ForeName": "Hosna", "Initials": "H"}, {"Identifier": ["0000-0003-1331-5303"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6734667149, Iran."}], "LastName": "Naseri", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": ["0000-0002-4572-2061"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biochemistry Division, Chemistry Department, Faculty of Science, Mansoura University, Mansoura 35516, Egypt."}], "LastName": "El-Senduny", "ForeName": "Fardous", "Initials": "F"}, {"Identifier": ["0000-0003-3957-3300"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Karaj, Iran."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), and Department of Toxicology and Pharmacology, School of Pharmacy, Tehran University of Medical Sciences, Tehran 1417614411, Iran."}, {"Identifier": [], "Affiliation": "Gastrointestinal Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": ["0000-0001-7081-6521"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6734667149, Iran."}], "LastName": "Farzaei", "ForeName": "Mohammad Hosein", "Initials": "MH"}, {"Identifier": ["0000-0002-1688-968X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departamento de Ciencias del Ambiente, Facultad de Qu\u00edmica y Biolog\u00eda, Universidad de Santiago de Chile, Santiago, Chile."}], "LastName": "Echeverr\u00eda", "ForeName": "Javier", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Egypt", "MedlineTA": "J Immunol Res", "NlmUniqueID": "101627166", "ISSNLinking": "2314-7156"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Autoimmunity"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Clinical Trials as Topic"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["methods"], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": ["drug effects", "immunology"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Quality of Life"}, {"QualifierName": ["diagnosis", "drug therapy", "immunology"], "DescriptorName": "Scleroderma, Systemic"}, {"QualifierName": [], "DescriptorName": "Severity of Illness Index"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}], "CoiStatement": "There is not any conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Patil U., Jaydeokar A., Bandawane D. Immunomodulators: a pharmacological review. International Journal of Pharmacy and Pharmaceutical Sciences. 2012;4(1):30\u201336."}, {"Citation": "Sultan M. T., Buttxs M. S., Qayyum M. M. N., Suleria H. A. R. Immunity: plants as effective mediators. Critical Reviews in Food Science and Nutrition. 2014;54(10):1298\u20131308. doi: 10.1080/10408398.2011.633249.", "ArticleIdList": ["10.1080/10408398.2011.633249", "24564587"]}, {"Citation": "Tan B. K., Vanitha J. Immunomodulatory and antimicrobial effects of some traditional Chinese medicinal herbs: a review. Current Medicinal Chemistry. 2004;11(11):1423\u20131430. doi: 10.2174/0929867043365161.", "ArticleIdList": ["10.2174/0929867043365161", "15180575"]}, {"Citation": "Bright J. J. Targeting autoimmune diseases through nutraceuticals. Nutrition. 2004;20(1):39\u201343. doi: 10.1016/j.nut.2003.09.007.", "ArticleIdList": ["10.1016/j.nut.2003.09.007", "14698012"]}, {"Citation": "Ma H.-D., Deng Y. R., Tian Z., Lian Z. X. Traditional Chinese medicine and immune regulation. Clinical Reviews in Allergy & Immunology. 2013;44(3):229\u2013241. doi: 10.1007/s12016-012-8332-0.", "ArticleIdList": ["10.1007/s12016-012-8332-0", "22826112"]}, {"Citation": "Rengasamy K. R., Khan H., Gowrishankar S., et al. The role of flavonoids in autoimmune diseases: therapeutic updates. Pharmacology & Therapeutics. 2019;194:107\u2013131. doi: 10.1016/j.pharmthera.2018.09.009.", "ArticleIdList": ["10.1016/j.pharmthera.2018.09.009", "30268770"]}, {"Citation": "Singh N., Tailang M., Mehta S. A review on herbal plants as immunomodulators. International Journal of Pharmaceutical Sciences and Research. 2016;7(9):p. 3602."}, {"Citation": "Karim A., Nouman Soh M., Munir S., Sattar S. Pharmacology and phytochemistry of Pakistani herbs and herbal drugs used for treatment of diabetes. International Journal of Pharmacology. 2011;7(4):419\u2013439. doi: 10.3923/ijp.2011.419.439.", "ArticleIdList": ["10.3923/ijp.2011.419.439"]}, {"Citation": "Harikrishnan R., Balasundaram C., Heo M.-S. Impact of plant products on innate and adaptive immune system of cultured finfish and shellfish. Aquaculture. 2011;317(1-4):1\u201315. doi: 10.1016/j.aquaculture.2011.03.039.", "ArticleIdList": ["10.1016/j.aquaculture.2011.03.039"]}, {"Citation": "Mukherjee P. K., Nema N. K., Bhadra S., Mukherjee D., Braga F. C., Matsabisa M. G.  India: NISCAIR-CSIR; 2014. Immunomodulatory leads from medicinal plants.  http://nopr.niscair.res.in/handle/123456789/27905."}, {"Citation": "Wagner H. Immunostimulants of plant origin. Croatica Chemica Acta. 1995;68(3):615\u2013626."}, {"Citation": "Sharma R., Rohilla A., Arya V. A short review on pharmacology of plant immunomodulators. International Journal of Pharmaceutical Sciences Review and Research. 2011;9:126\u2013131."}, {"Citation": "Amirghofran Z. Herbal medicines for immunosuppression. Iranian Journal of Allergy, Asthma and Immunology. 2012;11:111\u2013119.", "ArticleIdList": ["22761185"]}, {"Citation": "Cen J., Shi M., Yang Y., et al. Isogarcinol is a new immunosuppressant. PLoS One. 2013;8(6):p. e66503. doi: 10.1371/journal.pone.0066503.", "ArticleIdList": ["10.1371/journal.pone.0066503", "PMC3681756", "23785505"]}, {"Citation": "Cock I. E., Cheesman M. Bioactive Food as Dietary Interventions for Arthritis and Related Inflammatory Diseases. Elsevier; 2019. The potential of plants of the genus Syzygium (Myrtaceae) for the prevention and treatment of arthritic and autoimmune diseases; pp. 401\u2013424."}, {"Citation": "Li P., Zheng Y., Chen X. Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics. Frontiers in Pharmacology. 2017;8:p. 460. doi: 10.3389/fphar.2017.00460.", "ArticleIdList": ["10.3389/fphar.2017.00460", "PMC5506195", "28785220"]}, {"Citation": "Bragazzi N. L., Watad A., Brigo F., Adawi M., Amital H., Shoenfeld Y. Public health awareness of autoimmune diseases after the death of a celebrity. Clinical Rheumatology. 2017;36(8):1911\u20131917. doi: 10.1007/s10067-016-3513-5.", "ArticleIdList": ["10.1007/s10067-016-3513-5", "28000011"]}, {"Citation": "Rainsford K. Inflammation in the pathogenesis of chronic diseases. Springer; 2007. Anti-inflammatory drugs in the 21st century; pp. 3\u201327.", "ArticleIdList": ["17612044"]}, {"Citation": "Simmons D., Botting R. M., Hla T. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacological Reviews. 2004;56(3):387\u2013437. doi: 10.1124/pr.56.3.3.", "ArticleIdList": ["10.1124/pr.56.3.3", "15317910"]}, {"Citation": "Antman E. M., Bennett J. S., Daugherty A., et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115(12):1634\u20131642. doi: 10.1161/CIRCULATIONAHA.106.181424.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.106.181424", "17325246"]}, {"Citation": "Ray W. A., Stein C. M., Daugherty J. R., Hall K., Arbogast P. G., Griffin M. R. COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. The Lancet. 2002;360(9339):1071\u20131073. doi: 10.1016/S0140-6736(02)11131-7.", "ArticleIdList": ["10.1016/S0140-6736(02)11131-7", "12383990"]}, {"Citation": "Hermann M., Ruschitzka F. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk. Internal Medicine Journal. 2006;36(5):308\u2013319. doi: 10.1111/j.1445-5994.2006.01056.x.", "ArticleIdList": ["10.1111/j.1445-5994.2006.01056.x", "16650196"]}, {"Citation": "Glyn J. The discovery and early use of cortisone. Journal of the Royal Society of Medicine. 1998;91(10):513\u2013517. doi: 10.1177/014107689809101004.", "ArticleIdList": ["10.1177/014107689809101004", "PMC1296908", "10070369"]}, {"Citation": "Joana F., Alaa A., Paul E. Glucocorticoids and rhematoid arthritis. Rheumatic Diseases Clinics of North America. 2016;42:33\u201346.", "ArticleIdList": ["26611549"]}, {"Citation": "Buttgereit F., Burmester G. R., Straub R. H., Seibel M. J., Zhou H. Exogenous and endogenous glucocorticoids in rheumatic diseases. Arthritis and Rheumatism. 2011;63(1):1\u20139. doi: 10.1002/art.30070.", "ArticleIdList": ["10.1002/art.30070", "20936628"]}, {"Citation": "Barnes P. J. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clinical Science. 1998;94(6):557\u2013572. doi: 10.1042/cs0940557.", "ArticleIdList": ["10.1042/cs0940557", "9854452"]}, {"Citation": "Chen X., Oppenheim J.\u2004. J., Winkler-Pickett R.\u2004. T., Ortaldo J.\u2004. R., Howard O.\u2004. M.\u2004. Z. Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3+ CD4+ CD25+ T regulatory cells in vivo and enhances their capacity to suppress EAE. European Journal of Immunology. 2006;36(8):2139\u20132149. doi: 10.1002/eji.200635873.", "ArticleIdList": ["10.1002/eji.200635873", "16841298"]}, {"Citation": "Ethgen O., de Lemos Esteves F., Bruyere O., Reginster J. Y. What do we know about the safety of corticosteroids in rheumatoid arthritis? Current Medical Research and Opinion. 2013;29(9):1147\u20131160. doi: 10.1185/03007995.2013.818531.", "ArticleIdList": ["10.1185/03007995.2013.818531", "23790244"]}, {"Citation": "Gabriel S. E., Coyle D., Moreland L. W. A clinical and economic review of disease-modifying antirheumatic drugs. PharmacoEconomics. 2001;19(7):715\u2013728. doi: 10.2165/00019053-200119070-00002.", "ArticleIdList": ["10.2165/00019053-200119070-00002", "11548909"]}, {"Citation": "van Vollenhoven R. F., Geborek P., Forslind K., et al. Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial. The Lancet. 2012;379(9827):1712\u20131720. doi: 10.1016/S0140-6736(12)60027-0.", "ArticleIdList": ["10.1016/S0140-6736(12)60027-0", "22464340"]}, {"Citation": "Rosato E., Pisarri S., Salsano F. Current strategies for the treatment of autoimmune diseases. Journal of Biological Regulators and Homeostatic Agents. 2010;24(3):251\u2013259.", "ArticleIdList": ["20846473"]}, {"Citation": "Wells A. U. Interstitial lung disease in systemic sclerosis. La Presse M\u00e9dicale. 2014;43(10):e329\u2013e343. doi: 10.1016/j.lpm.2014.08.002.", "ArticleIdList": ["10.1016/j.lpm.2014.08.002", "25217474"]}, {"Citation": "Bernatsky S., Joseph L., Pineau C. A., Belisle P., Hudson M., Clarke A. E. Scleroderma prevalence: demographic variations in a population-based sample. Arthritis Care & Research. 2009;61(3):400\u2013404. doi: 10.1002/art.24339.", "ArticleIdList": ["10.1002/art.24339", "19248123"]}, {"Citation": "Nishioka K., Katayama I., Kondo H., et al. Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc) The Journal of Dermatology. 1996;23(10):677\u2013682. doi: 10.1111/j.1346-8138.1996.tb02680.x.", "ArticleIdList": ["10.1111/j.1346-8138.1996.tb02680.x", "8973032"]}, {"Citation": "Tamaki T., Mori S., Takehara K. Epidemiological study of patients with systemic sclerosis in Tokyo. Archives of Dermatological Research. 1991;283(6):366\u2013371. doi: 10.1007/BF00371817.", "ArticleIdList": ["10.1007/BF00371817", "1796818"]}, {"Citation": "Meier F. M., Frommer K. W., Dinser R., et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Annals of the Rheumatic Diseases. 2012;71(8):1355\u20131360. doi: 10.1136/annrheumdis-2011-200742.", "ArticleIdList": ["10.1136/annrheumdis-2011-200742", "22615460"]}, {"Citation": "Steen V., Domsic R. T., Lucas M., Fertig N., Medsger T. A., Jr. A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis. Arthritis and Rheumatism. 2012;64(9):2986\u20132994. doi: 10.1002/art.34482.", "ArticleIdList": ["10.1002/art.34482", "PMC3557827", "22576620"]}, {"Citation": "Skare T. L., Fonseca A. E., Luciano A. C., Azevedo P. M. Autoantibodies in scleroderma and their association with the clinical profile of the disease. A study of 66 patients from southern Brazil. Anais Brasileiros de Dermatologia. 2011;86(6):1075\u20131081. doi: 10.1590/S0365-05962011000600003.", "ArticleIdList": ["10.1590/S0365-05962011000600003", "22281893"]}, {"Citation": "Janardana R., Nair A. M., Surin A. K., Prakash J. A. J., Gowri M., Danda D. Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma\u2014do South Asians have a more aggressive disease? Clinical Rheumatology. 2019;38(11):3179\u20133187. doi: 10.1007/s10067-019-04659-2.", "ArticleIdList": ["10.1007/s10067-019-04659-2", "31309339"]}, {"Citation": "Pasarikovski C. R., Granton J. T., Roos A. M., et al. Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study. Arthritis Research & Therapy. 2016;18(1):p. 30. doi: 10.1186/s13075-016-0933-1.", "ArticleIdList": ["10.1186/s13075-016-0933-1", "PMC4729129", "26819137"]}, {"Citation": "Gabrielli A., Avvedimento E. V., Krieg T. Scleroderma. New England Journal of Medicine. 2009;360(19):1989\u20132003. doi: 10.1056/NEJMra0806188.", "ArticleIdList": ["10.1056/NEJMra0806188", "19420368"]}, {"Citation": "Soldano S., Montagna P., Brizzolara R., et al. Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. Annals of the New York Academy of Sciences. 2010;1193(1):25\u201329. doi: 10.1111/j.1749-6632.2009.05296.x.", "ArticleIdList": ["10.1111/j.1749-6632.2009.05296.x", "20398004"]}, {"Citation": "LeRoy E. C., Black C., Fleischmajer R., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. The Journal of Rheumatology. 1988;15(2):202\u2013205.", "ArticleIdList": ["3361530"]}, {"Citation": "Sobolewski P., Ma\u015bli\u0144ska M., Wieczorek M., et al. Systemic sclerosis - multidisciplinary disease: clinical features and treatment. Reumatologia. 2019;57(4):221\u2013233. doi: 10.5114/reum.2019.87619.", "ArticleIdList": ["10.5114/reum.2019.87619", "PMC6753596", "31548749"]}, {"Citation": "Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine. 1995;1(1):27\u201330. doi: 10.1038/nm0195-27.", "ArticleIdList": ["10.1038/nm0195-27", "7584949"]}, {"Citation": "Calvaruso V., Crax\u00ec A. Immunological alterations in hepatitis C virus infection. World journal of gastroenterology: WJG. 2013;19(47):8916\u20138923. doi: 10.3748/wjg.v19.i47.8916.", "ArticleIdList": ["10.3748/wjg.v19.i47.8916", "PMC3870544", "24379616"]}, {"Citation": "Gu Y. S., Kong J., Cheema G. S., Keen C. L., Wick G., Gershwin M. E. The immunobiology of systemic sclerosis. Seminars in Arthritis and Rheumatism. 2008;38(2):132\u2013160. doi: 10.1016/j.semarthrit.2007.10.010.", "ArticleIdList": ["10.1016/j.semarthrit.2007.10.010", "18221988"]}, {"Citation": "Sgonc R., Gruschwitz M. S., Boeck G., Sepp N., Gruber J., Wick G. Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis & Rheumatism. 2000;43(11):2550\u20132562. doi: 10.1002/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H.", "ArticleIdList": ["10.1002/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H", "11083280"]}, {"Citation": "Mavalia C., Scaletti C., Romagnani P., et al. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. The American Journal of Pathology. 1997;151(6):1751\u20131758.", "ArticleIdList": ["PMC1858349", "9403725"]}, {"Citation": "Giacomelli R., Matucci-Cerinic M., Cipriani P., et al. Circulating V\u03b41 + T cells are activated and accumulate in the skin of systemic sclerosis patients. Arthritis & Rheumatism. 1998;41(2):327\u2013334. doi: 10.1002/1529-0131(199802)41:2<327::AID-ART17>3.0.CO;2-S.", "ArticleIdList": ["10.1002/1529-0131(199802)41:2<327::AID-ART17>3.0.CO;2-S", "9485091"]}, {"Citation": "Kalogerou A., Gelou E., Mountantonakis S., Settas L., Zafiriou E., Sakkas L. Early T cell activation in the skin from patients with systemic sclerosis. Annals of the Rheumatic Diseases. 2005;64(8):1233\u20131235. doi: 10.1136/ard.2004.027094.", "ArticleIdList": ["10.1136/ard.2004.027094", "PMC1755597", "16014686"]}, {"Citation": "Kr\u00e4ling B. M., Maul G. G., Jimenez S. A. Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages. Pathobiology. 1995;63(1):48\u201356. doi: 10.1159/000163933.", "ArticleIdList": ["10.1159/000163933", "7546275"]}, {"Citation": "Seibold J. R., Giorno R. C., Claman H. N. Dermal mast cell degranulation in systemic sclerosis. Arthritis & Rheumatism. 1990;33(11):1702\u20131709. doi: 10.1002/art.1780331114.", "ArticleIdList": ["10.1002/art.1780331114", "2242067"]}, {"Citation": "Sato S., Hanakawa H., Hasegawa M., et al. Levels of interleukin 12, a cytokine of type 1 helper T cells, are elevated in sera from patients with systemic sclerosis. The Journal of Rheumatology. 2000;27(12):2838\u20132842.", "ArticleIdList": ["11128673"]}, {"Citation": "Komura K., Fujimoto M., Hasegawa M., et al. Increased serum interleukin 23 in patients with systemic sclerosis. The Journal of Rheumatology. 2008;35(1):120\u2013125.", "ArticleIdList": ["18085738"]}, {"Citation": "Yoshizaki A., Yanaba K., Iwata Y., et al. Elevated serum interleukin-27 levels in patients with systemic sclerosis: association with T cell, B cell and fibroblast activation. Annals of the Rheumatic Diseases. 2011;70(1):194\u2013200. doi: 10.1136/ard.2009.121053.", "ArticleIdList": ["10.1136/ard.2009.121053", "20705635"]}, {"Citation": "Varga J., Denton C. P. Kelley\u2019s Textbook of Rheumatology. 8th. USA: Saunders Elsevier; 2009. Scleroderma, inflammatory myopathies, and overlap syndromes; pp. 1311\u20131351."}, {"Citation": "Wakhlu A., Sahoo R. R., Parida J. R., et al. Serum interleukin-6, interleukin-17A, and transforming growth factor beta are raised in systemic sclerosis with interstitial lung disease. Indian Journal of Rheumatology. 2018;13(2):107\u2013112. doi: 10.4103/injr.injr_106_17.", "ArticleIdList": ["10.4103/injr.injr_106_17"]}, {"Citation": "Klareskog L., Gustafsson R., Scheynius A., H\u00e4llgren R. Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis. Arthritis & Rheumatism. 1990;33(10):1534\u20131541. doi: 10.1002/art.1780331011.", "ArticleIdList": ["10.1002/art.1780331011", "2171541"]}, {"Citation": "Gay S., Jones R. E., Jr., Huang G. Q., Gay R. E. Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma. Journal of Investigative Dermatology. 1989;92(2):301\u2013303. doi: 10.1111/1523-1747.ep12276895.", "ArticleIdList": ["10.1111/1523-1747.ep12276895", "2918236"]}, {"Citation": "Kaplan K. L., Broekman M. J., Chernoff A., Lesznik G. R., Drillings M. Platelet alpha-granule proteins: studies on release and subcellular localization. Blood. 1979;53(4):604\u2013618. doi: 10.1182/blood.V53.4.604.604.", "ArticleIdList": ["10.1182/blood.V53.4.604.604", "426909"]}, {"Citation": "Heldin C.-H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiological Reviews. 1999;79(4):1283\u20131316. doi: 10.1152/physrev.1999.79.4.1283.", "ArticleIdList": ["10.1152/physrev.1999.79.4.1283", "10508235"]}, {"Citation": "Prescott R. J., Freemont A. J., Jones C. J. P., Hoyland J., Fielding P. Sequential dermal microvascular and perivascular changes in the development of scleroderma. The Journal of Pathology. 1992;166(3):255\u2013263. doi: 10.1002/path.1711660307.", "ArticleIdList": ["10.1002/path.1711660307", "1517881"]}, {"Citation": "Dziadzio M., Smith R. E., Abraham D. J., Black C. M., Denton C. P. Circulating levels of active transforming growth factor \u03b21 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score. Rheumatology. 2005;44(12):1518\u20131524. doi: 10.1093/rheumatology/kei088.", "ArticleIdList": ["10.1093/rheumatology/kei088", "16159952"]}, {"Citation": "Higley H., Persichitte K., Chu S., Waegell W., Vancheeswaran R., Black C. Immunocytochemical localization and serologic detection of transforming growth factor \u03b21. Arthritis & Rheumatism. 1994;37(2):278\u2013288. doi: 10.1002/art.1780370218.", "ArticleIdList": ["10.1002/art.1780370218", "7510487"]}, {"Citation": "O'Reilly S., Ciechomska M., Cant R., van Laar J. M. IL-6 trans signalling drives a STAT3 dependant pathway that leads to hyperactive TGF-\u03b2 signalling promoting SMAD3 activation and fibrosis via gremlin. Journal of Biological Chemistry. 2014;289(14) doi: 10.1074/jbc.M113.545822.", "ArticleIdList": ["10.1074/jbc.M113.545822", "PMC3975039", "24550394"]}, {"Citation": "Asano Y., Ihn H., Yamane K., Kubo M., Tamaki K. Impaired Smad7-Smurf\u2013mediated negative regulation of TGF-\u03b2 signaling in scleroderma fibroblasts. The Journal of Clinical Investigation. 2004;113(2):253\u2013264. doi: 10.1172/JCI16269.", "ArticleIdList": ["10.1172/JCI16269", "PMC310747", "14722617"]}, {"Citation": "Ide M., Jinnin M., Tomizawa Y., et al. Transforming growth factor \u03b2-inhibitor Repsox downregulates collagen expression of scleroderma dermal fibroblasts and prevents bleomycin-induced mice skin fibrosis. Experimental Dermatology. 2017;26(11):1139\u20131143. doi: 10.1111/exd.13366.", "ArticleIdList": ["10.1111/exd.13366", "28418584"]}, {"Citation": "Komatsu H., Chao M. Y., Larkins-Ford J., et al. OSM-11 facilitates LIN-12 Notch signaling during Caenorhabditis elegans vulval development. PLoS Biology. 2008;6(8, article e196) doi: 10.1371/journal.pbio.0060196.", "ArticleIdList": ["10.1371/journal.pbio.0060196", "PMC2504490", "18700817"]}, {"Citation": "Kopan R., Ilagan M. X. G. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216\u2013233. doi: 10.1016/j.cell.2009.03.045.", "ArticleIdList": ["10.1016/j.cell.2009.03.045", "PMC2827930", "19379690"]}, {"Citation": "Logeat F., Bessia C., Brou C., et al. The Notch1 receptor is cleaved constitutively by a furin-like convertase. Proceedings of the National Academy of Sciences. 1998;95(14):8108\u20138112. doi: 10.1073/pnas.95.14.8108.", "ArticleIdList": ["10.1073/pnas.95.14.8108", "PMC20937", "9653148"]}, {"Citation": "Gridley T. Notch signaling in vascular development and physiology. Development. 2007;134(15):2709\u20132718. doi: 10.1242/dev.004184.", "ArticleIdList": ["10.1242/dev.004184", "17611219"]}, {"Citation": "Hu B., Phan S. H. Notch in fibrosis and as a target of anti-fibrotic therapy. Pharmacological Research. 2016;108:57\u201364. doi: 10.1016/j.phrs.2016.04.010.", "ArticleIdList": ["10.1016/j.phrs.2016.04.010", "PMC5074914", "27107790"]}, {"Citation": "Gorlova O., Martin J. E., Rueda B., et al. Correction: identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genetics. 2011;7(8) doi: 10.1371/annotation/7a52649c-0942-4bd8-a5d3-3cdacca03cd8.", "ArticleIdList": ["10.1371/annotation/7a52649c-0942-4bd8-a5d3-3cdacca03cd8", "PMC3136437", "21779181"]}, {"Citation": "Cardinale C. J., Li D., Tian L., et al. Association of a rare NOTCH4 coding variant with systemic sclerosis: a family-based whole exome sequencing study. BMC Musculoskeletal Disorders. 2016;17(1):p. 462. doi: 10.1186/s12891-016-1320-4.", "ArticleIdList": ["10.1186/s12891-016-1320-4", "PMC5103422", "27829420"]}, {"Citation": "Tsou P. S., Sawalha A. H. Unfolding the pathogenesis of scleroderma through genomics and epigenomics. Journal of Autoimmunity. 2017;83:73\u201394. doi: 10.1016/j.jaut.2017.05.004.", "ArticleIdList": ["10.1016/j.jaut.2017.05.004", "PMC5573604", "28526340"]}, {"Citation": "Warde N. Notch signaling: an important player in SSc fibrosis. Nature Reviews Rheumatology. 2011;7(6):312\u2013312. doi: 10.1038/nrrheum.2011.55.", "ArticleIdList": ["10.1038/nrrheum.2011.55", "21637309"]}, {"Citation": "Dees C., Tomcik M., Zerr P., et al. Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis. Annals of the Rheumatic Diseases. 2011;70(7):1304\u20131310. doi: 10.1136/ard.2010.134742.", "ArticleIdList": ["10.1136/ard.2010.134742", "21450749"]}, {"Citation": "Schwartz D. M., Kanno Y., Villarino A., Ward M., Gadina M., O'Shea J. J. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases. Nature Reviews Drug Discovery. 2017;16(12):843\u2013862. doi: 10.1038/nrd.2017.201.", "ArticleIdList": ["10.1038/nrd.2017.201", "29104284"]}, {"Citation": "Avouac J., F\u00fcrnrohr B. G., Tomcik M., et al. Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis. Arthritis and Rheumatism. 2011;63(3):800\u2013809. doi: 10.1002/art.30171.", "ArticleIdList": ["10.1002/art.30171", "21360510"]}, {"Citation": "Khanna D., Denton C. P., Lin C. J. F., et al. Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate) Annals of the Rheumatic Diseases. 2018;77(2):212\u2013220. doi: 10.1136/annrheumdis-2017-211682.", "ArticleIdList": ["10.1136/annrheumdis-2017-211682", "PMC5867414", "29066464"]}, {"Citation": "Denton C. P., Ong V. H., Xu S., et al. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis. Annals of the Rheumatic Diseases. 2018;77(9):1362\u20131371. doi: 10.1136/annrheumdis-2018-213031.", "ArticleIdList": ["10.1136/annrheumdis-2018-213031", "PMC6104680", "29853453"]}, {"Citation": "Berekmeri A., Mahmood F., Wittmann M., Helliwell P. Tofacitinib for the treatment of psoriasis and psoriatic arthritis. Expert Review of Clinical Immunology. 2018;14(9):719\u2013730. doi: 10.1080/1744666X.2018.1512404.", "ArticleIdList": ["10.1080/1744666X.2018.1512404", "30118353"]}, {"Citation": "Wang W., Bhattacharyya S., Marangoni R. G., et al. The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib. Journal of Scleroderma and Related Disorders. 2019;5:40\u201350. doi: 10.1177/2397198319865367.", "ArticleIdList": ["10.1177/2397198319865367", "PMC8922593", "35382402"]}, {"Citation": "Hemmings B. A., Restuccia D. F. PI3K-PKB/Akt pathway. Cold Spring Harbor Perspectives in Biology. 2012;4(9, article a011189) doi: 10.1101/cshperspect.a011189.", "ArticleIdList": ["10.1101/cshperspect.a011189", "PMC3428770", "22952397"]}, {"Citation": "Darby I. A., Hewitson T. D. Hypoxia in tissue repair and fibrosis. Cell and Tissue Research. 2016;365(3):553\u2013562. doi: 10.1007/s00441-016-2461-3.", "ArticleIdList": ["10.1007/s00441-016-2461-3", "27423661"]}, {"Citation": "Ioannou M., Pyrpasopoulou A., Simos G., et al. Upregulation of VEGF expression is associated with accumulation of HIF-1\u03b1 in the skin of na\u00efve scleroderma patients. Modern Rheumatology. 2013;23(6):1245\u20131248. doi: 10.3109/s10165-012-0787-6.", "ArticleIdList": ["10.3109/s10165-012-0787-6", "23096096"]}, {"Citation": "Chang F., Steelman L. S., Lee J. T., et al. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia. 2003;17(7):1263\u20131293. doi: 10.1038/sj.leu.2402945.", "ArticleIdList": ["10.1038/sj.leu.2402945", "12835716"]}, {"Citation": "Chen Y., Shi-wen X., van Beek J., et al. Matrix contraction by dermal fibroblasts requires transforming growth factor-\u03b2/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease. The American Journal of Pathology. 2005;167(6):1699\u20131711. doi: 10.1016/S0002-9440(10)61252-7.", "ArticleIdList": ["10.1016/S0002-9440(10)61252-7", "PMC1613194", "16314481"]}, {"Citation": "Shi-wen X., Howat S. L., Renzoni E. A., et al. Endothelin-1 induces expression of matrix-associated genes in lung fibroblasts through MEK/ERK. Journal of Biological Chemistry. 2004;279(22):23098\u201323103. doi: 10.1074/jbc.M311430200.", "ArticleIdList": ["10.1074/jbc.M311430200", "15044479"]}, {"Citation": "Cronstein B. N., Weissmann G. The adhesion molecules of inflammation. Arthritis and Rheumatism. 1993;36(2):147\u2013157. doi: 10.1002/art.1780360204.", "ArticleIdList": ["10.1002/art.1780360204", "8431203"]}, {"Citation": "Ihn H., Fujimoto M., Sato S., et al. Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma. Journal of the American Academy of Dermatology. 1994;31(4):591\u2013595. doi: 10.1016/S0190-9622(94)70221-7.", "ArticleIdList": ["10.1016/S0190-9622(94)70221-7", "7916356"]}, {"Citation": "Carson C., Beall L. D., Hunder G. G., Johnson C. M., Newman W. Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus. The Journal of Rheumatology. 1993;20(5):809\u2013814.", "ArticleIdList": ["7687701"]}, {"Citation": "Gruschwitz M. S., Hornstein O. P., Driesch P. V. D. Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis & Rheumatism. 1995;38(2):184\u2013189. doi: 10.1002/art.1780380206.", "ArticleIdList": ["10.1002/art.1780380206", "7848308"]}, {"Citation": "Claman H. N., Giorno R. C., Seibold J. R. Endothelial and fibroblastic activation in scleroderma: the myth of the \u201cuninvolved skin\u201d. Arthritis and Rheumatism. 1991;34(12):1495\u20131501. doi: 10.1002/art.1780341204.", "ArticleIdList": ["10.1002/art.1780341204", "1720957"]}, {"Citation": "Distler O., Pap T., Kowal-Bielecka O., et al. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis. Arthritis and Rheumatism. 2001;44(11):2665\u20132678. doi: 10.1002/1529-0131(200111)44:11<2665::AID-ART446>3.0.CO;2-S.", "ArticleIdList": ["10.1002/1529-0131(200111)44:11<2665::AID-ART446>3.0.CO;2-S", "11710722"]}, {"Citation": "Asano Y., Ihn H., Yamane K., Jinnin M., Mimura Y., Tamaki K. Increased expression of integrin \u03b1v\u03b23contributes to the establishment of autocrine TGF-\u03b2 signaling in scleroderma fibroblasts. The Journal of Immunology. 2005;175(11):7708\u20137718. doi: 10.4049/jimmunol.175.11.7708.", "ArticleIdList": ["10.4049/jimmunol.175.11.7708", "16301681"]}, {"Citation": "Gruschwitz M., Albrecht M., Vieth G., Haustein U. F. In situ expression and serum levels of tumor necrosis factor-alpha receptors in patients with early stages of systemic sclerosis. The Journal of Rheumatology. 1997;24(10):1936\u20131943.", "ArticleIdList": ["9330935"]}, {"Citation": "Kawaguchi Y. IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis. Clinical & Experimental Immunology. 1994;97(3):445\u2013450. doi: 10.1111/j.1365-2249.1994.tb06108.x.", "ArticleIdList": ["10.1111/j.1365-2249.1994.tb06108.x", "PMC1534852", "8082299"]}, {"Citation": "Kawaguchi Y., Harigai M., Suzuki K., et al. Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1\u03b2. Biochemical and Biophysical Research Communications. 1993;190(1):154\u2013161. doi: 10.1006/bbrc.1993.1024.", "ArticleIdList": ["10.1006/bbrc.1993.1024", "8422241"]}, {"Citation": "Jelaska A., Korn J. H. Role of apoptosis and transforming growth factor \u03b21 in fibroblast selection and activation in systemic sclerosis. Arthritis & Rheumatism. 2000;43(10):2230\u20132239. doi: 10.1002/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8.", "ArticleIdList": ["10.1002/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8", "11037882"]}, {"Citation": "Samuel G. H., Lenna S., Bujor A. M., Lafyatis R., Trojanowska M. Acid sphingomyelinase deficiency contributes to resistance of scleroderma fibroblasts to Fas-mediated apoptosis. Journal of Dermatological Science. 2012;67(3):166\u2013172. doi: 10.1016/j.jdermsci.2012.06.001.", "ArticleIdList": ["10.1016/j.jdermsci.2012.06.001", "PMC3423203", "22771321"]}, {"Citation": "SJ K., CB H. Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. 1972.   http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=PASCAL7334010484.", "ArticleIdList": ["5075520"]}, {"Citation": "Pullar J. M., Vissers M. C., Winterbourn C. C. Living with a killer: the effects of hypochlorous acid on mammalian cells. IUBMB Life. 2000;50(4):259\u2013266. doi: 10.1080/15216540051080958.", "ArticleIdList": ["10.1080/15216540051080958", "11327319"]}, {"Citation": "Sies H. Oxidative stress: oxidants and antioxidants. Experimental Physiology. 1997;82(2):291\u2013295. doi: 10.1113/expphysiol.1997.sp004024.", "ArticleIdList": ["10.1113/expphysiol.1997.sp004024", "9129943"]}, {"Citation": "Murrell D. F. A radical proposal for the pathogenesis of scleroderma. Journal of the American Academy of Dermatology. 1993;28(1):78\u201385. doi: 10.1016/0190-9622(93)70014-K.", "ArticleIdList": ["10.1016/0190-9622(93)70014-K", "8425975"]}, {"Citation": "Gabrielli A., Svegliati S., Moroncini G., Pomponio G., Santillo M., Avvedimento E. V. Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. Seminars in Immunopathology. 2008;30(3):329\u2013337. doi: 10.1007/s00281-008-0125-4.", "ArticleIdList": ["10.1007/s00281-008-0125-4", "18548250"]}, {"Citation": "Gabrielli A., Svegliati S., Moroncini G., Amico D. New insights into the role of oxidative stress in scleroderma fibrosis. Open Rheumatol J. 2012;6(1):87\u201395. doi: 10.2174/1874312901206010087.", "ArticleIdList": ["10.2174/1874312901206010087", "PMC3395898", "22802906"]}, {"Citation": "Grygiel-G\u00f3rniak B., Puszczewicz M. Oxidative damage and antioxidative therapy in systemic sclerosis. Mediators of Inflammation. 2014;2014:11. doi: 10.1155/2014/389582.389582", "ArticleIdList": ["10.1155/2014/389582", "PMC4172878", "25313270"]}, {"Citation": "Boin F., Erre G. L., Posadino A. M., et al. Oxidative stress-dependent activation of collagen synthesis is induced in human pulmonary smooth muscle cells by sera from patients with scleroderma-associated pulmonary hypertension. Orphanet Journal of Rare Diseases. 2014;9(1):p. 123. doi: 10.1186/s13023-014-0123-7.", "ArticleIdList": ["10.1186/s13023-014-0123-7", "PMC4237898", "25085432"]}, {"Citation": "Jiang M., Yu Y., Luo J., et al. Bone marrow-derived mesenchymal stem cells expressing thioredoxin 1 attenuate bleomycin-induced skin fibrosis and oxidative stress in scleroderma. The Journal of Investigative Dermatology. 2017;137(6):1223\u20131233. doi: 10.1016/j.jid.2017.01.011.", "ArticleIdList": ["10.1016/j.jid.2017.01.011", "28132855"]}, {"Citation": "Sambo P., Amico D., Giacomelli R., et al. Intravenous N-acetylcysteine for treatment of Raynaud's phenomenon secondary to systemic sclerosis: a pilot study. The Journal of Rheumatology. 2001;28(10):2257\u20132262.", "ArticleIdList": ["11669166"]}, {"Citation": "Failli P., Palmieri L., D\u2019Alfonso C., et al. Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis. Nitric Oxide. 2002;7(4):277\u2013282. doi: 10.1016/S1089-8603(02)00120-9.", "ArticleIdList": ["10.1016/S1089-8603(02)00120-9", "12446176"]}, {"Citation": "Demedts M., Behr J., Buhl R., et al. High-dose acetylcysteine in idiopathic pulmonary fibrosis. New England Journal of Medicine. 2005;353(21):2229\u20132242. doi: 10.1056/NEJMoa042976.", "ArticleIdList": ["10.1056/NEJMoa042976", "16306520"]}, {"Citation": "Zhou C. F., Yu J. F., Zhang J. X., et al. N-acetylcysteine attenuates subcutaneous administration of bleomycin-induced skin fibrosis and oxidative stress in a mouse model of scleroderma. Clinical and Experimental Dermatology. 2013;38(4):403\u2013409. doi: 10.1111/ced.12033.", "ArticleIdList": ["10.1111/ced.12033", "23517443"]}, {"Citation": "Tsou P. S., Talia N. N., Pinney A. J., et al. Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts. Arthritis and Rheumatism. 2012;64(6):1978\u20131989. doi: 10.1002/art.34336.", "ArticleIdList": ["10.1002/art.34336", "PMC3309078", "22161819"]}, {"Citation": "Sgonc R., Gruschwitz M. S., Dietrich H., Recheis H., Gershwin M. E., Wick G. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. The Journal of Clinical Investigation. 1996;98(3):785\u2013792. doi: 10.1172/JCI118851.", "ArticleIdList": ["10.1172/JCI118851", "PMC507489", "8698871"]}, {"Citation": "Yamamoto T., Nishioka K. Possible role of apoptosis in the pathogenesis of bleomycin-induced scleroderma. The Journal of Investigative Dermatology. 2004;122(1):44\u201350. doi: 10.1046/j.0022-202X.2003.22121.x.", "ArticleIdList": ["10.1046/j.0022-202X.2003.22121.x", "14962088"]}, {"Citation": "Kessel A., Rosner I., Rozenbaum M., et al. Increased CD8+ T cell apoptosis in scleroderma is associated with low levels of NF-kappa B. Journal of Clinical Immunology. 2004;24(1):30\u201336. doi: 10.1023/B:JOCI.0000018060.36183.bb.", "ArticleIdList": ["10.1023/B:JOCI.0000018060.36183.bb", "14997031"]}, {"Citation": "Ha M., Kim V. N. Regulation of microRNA biogenesis. Nature Reviews Molecular Cell Biology. 2014;15(8):509\u2013524. doi: 10.1038/nrm3838.", "ArticleIdList": ["10.1038/nrm3838", "25027649"]}, {"Citation": "Vasudevan S. Posttranscriptional upregulation by microRNAs. Wiley Interdisciplinary Reviews: RNA. 2012;3(3):311\u2013330. doi: 10.1002/wrna.121.", "ArticleIdList": ["10.1002/wrna.121", "22072587"]}, {"Citation": "Makarova J. A., Shkurnikov M. U., Wicklein D., et al. Intracellular and extracellular microRNA: an update on localization and biological role. Progress in Histochemistry and Cytochemistry. 2016;51(3-4):33\u201349. doi: 10.1016/j.proghi.2016.06.001.", "ArticleIdList": ["10.1016/j.proghi.2016.06.001", "27396686"]}, {"Citation": "Fu G., Brki\u0107 J., Hayder H., Peng C. MicroRNAs in human placental development and pregnancy complications. International Journal of Molecular Sciences. 2013;14(3):5519\u20135544. doi: 10.3390/ijms14035519.", "ArticleIdList": ["10.3390/ijms14035519", "PMC3634453", "23528856"]}, {"Citation": "Peng Y., Croce C. M. The role of microRNAs in human cancer. Signal Transduction and Targeted Therapy. 2016;1(1):1\u20139.", "ArticleIdList": ["PMC5661652", "29263891"]}, {"Citation": "Koba S., Jinnin M., Inoue K., et al. Expression analysis of multiple microRNAs in each patient with scleroderma. Experimental Dermatology. 2013;22(7):489\u2013491. doi: 10.1111/exd.12173.", "ArticleIdList": ["10.1111/exd.12173", "23800063"]}, {"Citation": "Honda N., Jinnin M., Kajihara I., et al. TGF-\u03b2\u2013mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts. The Journal of Immunology. 2012;188(7):3323\u20133331. doi: 10.4049/jimmunol.1100876.", "ArticleIdList": ["10.4049/jimmunol.1100876", "22379029"]}, {"Citation": "Makino K., Jinnin M., Hirano A., et al. The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma. The Journal of Immunology. 2013;190(8):3905\u20133915. doi: 10.4049/jimmunol.1200822.", "ArticleIdList": ["10.4049/jimmunol.1200822", "23509348"]}, {"Citation": "Sing T., Jinnin M., Yamane K., et al. MicroRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma. Rheumatology. 2012;51(9):1550\u20131556. doi: 10.1093/rheumatology/kes120.", "ArticleIdList": ["10.1093/rheumatology/kes120", "22661558"]}, {"Citation": "Honda N., Jinnin M., Kira-Etoh T., et al. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin \u03b23. The American Journal of Pathology. 2013;182(1):206\u2013216. doi: 10.1016/j.ajpath.2012.09.023.", "ArticleIdList": ["10.1016/j.ajpath.2012.09.023", "23159943"]}, {"Citation": "Nakayama W., Jinnin M., Tomizawa Y., et al. Dysregulated interleukin-23 signalling contributes to the increased collagen production in scleroderma fibroblasts via balancing microRNA expression. Rheumatology (Oxford) 2017;56(1):145\u2013155. doi: 10.1093/rheumatology/kew336.", "ArticleIdList": ["10.1093/rheumatology/kew336", "27744356"]}, {"Citation": "Eddouks M., Lemhadri A., Michel J.-B. Caraway and caper: potential anti-hyperglycaemic plants in diabetic rats. Journal of Ethnopharmacology. 2004;94(1):143\u2013148. doi: 10.1016/j.jep.2004.05.006.", "ArticleIdList": ["10.1016/j.jep.2004.05.006", "15261975"]}, {"Citation": "Cao Y.-l., Li X., Zheng M. Capparis spinosa protects against oxidative stress in systemic sclerosis dermal fibroblasts. Archives of Dermatological Research. 2010;302(5):349\u2013355. doi: 10.1007/s00403-009-0998-7.", "ArticleIdList": ["10.1007/s00403-009-0998-7", "19851777"]}, {"Citation": "Dong L., Fan L., Li G. F., Guo Y., Pan J., Chen Z. W. Anti-aging action of the total lactones of ginkgo on aging mice. Acta Pharmaceutica Sinica. 2004;39(3):176\u2013179.", "ArticleIdList": ["15171650"]}, {"Citation": "Tan M.-S., Yu J. T., Tan C. C., et al. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. Journal of Alzheimer's Disease. 2015;43(2):589\u2013603. doi: 10.3233/JAD-140837.", "ArticleIdList": ["10.3233/JAD-140837", "25114079"]}, {"Citation": "Smith J., Luo Y. Studies on molecular mechanisms of Ginkgo biloba extract. Applied Microbiology and Biotechnology. 2004;64(4):465\u2013472. doi: 10.1007/s00253-003-1527-9.", "ArticleIdList": ["10.1007/s00253-003-1527-9", "14740187"]}, {"Citation": "Mirfeizi Z., Jokar M., Mirfeizi M. Ginkgo biloba reduces the duration and severity of Raynaud's attacks of patients with systemic sclerosis. Clinical and Experimental Rheumatology. 2014;32(2):S72\u2013S72.", "ArticleIdList": ["0"]}, {"Citation": "Nagata Y., Goto H., Hikiami H., et al. Effect of keishibukuryogan on endothelial function in patients with at least one component of the diagnostic criteria for metabolic syndrome: a controlled clinical trial with crossover design. Evidence-based Complementary and Alternative Medicine. 2012;2012:10. doi: 10.1155/2012/359282.359282", "ArticleIdList": ["10.1155/2012/359282", "PMC3364603", "22675380"]}, {"Citation": "Wang Q., Shi G., Zhang Y., et al. Deciphering the potential pharmaceutical mechanism of GUI-ZHI-FU-LING-WAN on systemic sclerosis based on systems biology approaches. Scientific Reports. 2019;9(1):1\u201313. doi: 10.1038/s41598-018-36314-2.", "ArticleIdList": ["10.1038/s41598-018-36314-2", "PMC6344516", "30674993"]}, {"Citation": "Sheng F. Y., Ohta A., Yamaguchi M. Inhibition of collagen production by traditional Chinese herbal medicine in scleroderma fibroblast cultures. Internal Medicine. 1994;33(8):466\u2013471. doi: 10.2169/internalmedicine.33.466.", "ArticleIdList": ["10.2169/internalmedicine.33.466", "7803912"]}, {"Citation": "Martin M., Tooke J. Effects of prostaglandin E1 on microvascular haemodynamics in progressive systemic sclerosis. British Medical Journal (Clinical Research Ed.) 1982;285(6356):1688\u20131690. doi: 10.1136/bmj.285.6356.1688.", "ArticleIdList": ["10.1136/bmj.285.6356.1688", "PMC1500707", "6816332"]}, {"Citation": "Belch J. J. F., Shaw B., O\u2019Dowd A., et al. Evening primrose oil (Efamol) in the treatment of Raynaud\u2019s phenomenon: a double blind study. Thrombosis and Haemostasis. 1985;53(2):490\u2013494. doi: 10.1055/s-0038-1657880.", "ArticleIdList": ["10.1055/s-0038-1657880", "4082084"]}, {"Citation": "Strong A., Campbell A., Thomson J. The effect of oral linoleic acid and gamma-linolenic acid (Efamol [G]) The British Journal of Clinical Practice. 1985;39(11-12):444\u2013445.", "ArticleIdList": ["4092010"]}, {"Citation": "Christiansen B. A., Bhatti S., Goudarzi R., Emami S. Management of osteoarthritis with avocado/soybean unsaponifiables. Cartilage. 2015;6(1):30\u201344. doi: 10.1177/1947603514554992.", "ArticleIdList": ["10.1177/1947603514554992", "PMC4303902", "25621100"]}, {"Citation": "Altinel L., Saritas Z. K., Kose K. C., Pamuk K., Aksoy Y., Serteser M. Treatment with unsaponifiable extracts of avocado and soybean increases TGF-.BETA.1 and TGF-.BETA.2 levels in canine joint fluid. The Tohoku Journal of Experimental Medicine. 2007;211(2):181\u2013186. doi: 10.1620/tjem.211.181.", "ArticleIdList": ["10.1620/tjem.211.181", "17287602"]}, {"Citation": "He F.-J., Chen J.-Q. Consumption of soybean, soy foods, soy isoflavones and breast cancer incidence: differences between Chinese women and women in Western countries and possible mechanisms. Food Science and Human Wellness. 2013;2(3-4):146\u2013161. doi: 10.1016/j.fshw.2013.08.002.", "ArticleIdList": ["10.1016/j.fshw.2013.08.002"]}, {"Citation": "Ownby S. L., Fortuno L. V., Au A. Y., Grzanna M. W., Rashmir-Raven A. M., Frondoza C. G. Expression of pro-inflammatory mediators is inhibited by an avocado/soybean unsaponifiables and epigallocatechin gallate combination. Journal of Inflammation. 2014;11(1):p. 8. doi: 10.1186/1476-9255-11-8.", "ArticleIdList": ["10.1186/1476-9255-11-8", "PMC3983882", "24678847"]}, {"Citation": "Jablonska S. Avocado/soybean unsaponifiables in the treatment of scleroderma: comment on the article by Maheu et al. Arthritis & Rheumatism. 1998;41(9):1705\u20131705. doi: 10.1002/1529-0131(199809)41:9<1705::AID-ART27>3.0.CO;2-5.", "ArticleIdList": ["10.1002/1529-0131(199809)41:9<1705::AID-ART27>3.0.CO;2-5", "9751109"]}, {"Citation": "Lv M., Deng J., Tang N., Zeng Y., Lu C. Efficacy and safety of Tripterygium wilfordii Hook F on psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials. Evidence-based Complementary and Alternative Medicine. 2018;2018:10. doi: 10.1155/2018/2623085.2623085", "ArticleIdList": ["10.1155/2018/2623085", "PMC5937555", "29849698"]}, {"Citation": "Lv Q. W., Zhang W., Shi Q., et al. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial. Annals of the Rheumatic Diseases. 2015;74(6):1078\u20131086.", "ArticleIdList": ["24733191"]}, {"Citation": "Yang L., Wang Q., Hou Y., et al. The Chinese herb Tripterygium wilfordii Hook F for the treatment of systemic sclerosis-associated interstitial lung disease: data from a Chinese EUSTAR Center. Clinical Rheumatology. 2020;39(3):813\u2013821. doi: 10.1007/s10067-019-04784-y.", "ArticleIdList": ["10.1007/s10067-019-04784-y", "31713733"]}, {"Citation": "Song X., Wang J., Wang P., Tian N., Yang M., Kong L. 1H NMR-based metabolomics approach to evaluate the effect of Xue-Fu-Zhu-Yu decoction on hyperlipidemia rats induced by high-fat diet. Journal of Pharmaceutical and Biomedical Analysis. 2013;78-79:202\u2013210. doi: 10.1016/j.jpba.2013.02.014.", "ArticleIdList": ["10.1016/j.jpba.2013.02.014", "23501440"]}, {"Citation": "Wen-ling W., You-ming S., Rong-ya Y., Jie Z., Yang X. Follow-up efficacy of integrative Chinese and Western drugs on localized scleroderma with vitamine B 6 and Xuefu Zhuyu decoction. Chinese Journal of Integrative Medicine. 2005;11(1):34\u201336. doi: 10.1007/BF02835746.", "ArticleIdList": ["10.1007/BF02835746", "15975305"]}, {"Citation": "Magnone M., Bruzzone S., Guida L., et al. Abscisic acid released by human monocytes activates monocytes and vascular smooth muscle cell responses involved in atherogenesis. Journal of Biological Chemistry. 2009;284(26):17808\u201317818. doi: 10.1074/jbc.M809546200.", "ArticleIdList": ["10.1074/jbc.M809546200", "PMC2719419", "19332545"]}, {"Citation": "Bruzzone S., Battaglia F., Mannino E., et al. Abscisic acid ameliorates the systemic sclerosis fibroblast phenotype in vitro. Biochemical and Biophysical Research Communications. 2012;422(1):70\u201374. doi: 10.1016/j.bbrc.2012.04.107.", "ArticleIdList": ["10.1016/j.bbrc.2012.04.107", "22560900"]}, {"Citation": "Pataki T., Bak I., Kovacs P., Bagchi D., Das D. K., Tosaki A. Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts. The American Journal of Clinical Nutrition. 2002;75(5):894\u2013899. doi: 10.1093/ajcn/75.5.894.", "ArticleIdList": ["10.1093/ajcn/75.5.894", "11976164"]}, {"Citation": "Kalfin R., Righi A., del Rosso A., et al. Activin, a grape seed-derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. Free Radical Research. 2002;36(8):819\u2013825. doi: 10.1080/1071576021000005249.", "ArticleIdList": ["10.1080/1071576021000005249", "12420739"]}, {"Citation": "Shin I.-S., Hong J., Jeon C. M., et al. Diallyl-disulfide, an organosulfur compound of garlic, attenuates airway inflammation via activation of the Nrf-2/HO-1 pathway and NF-kappaB suppression. Food and Chemical Toxicology. 2013;62:506\u2013513. doi: 10.1016/j.fct.2013.09.012.", "ArticleIdList": ["10.1016/j.fct.2013.09.012", "24051194"]}, {"Citation": "Zhou J., Qu Z., Yan S., et al. Differential roles of STAT3 in the initiation and growth of lung cancer. Oncogene. 2015;34(29):3804\u20133814. doi: 10.1038/onc.2014.318.", "ArticleIdList": ["10.1038/onc.2014.318", "PMC4387125", "25284582"]}, {"Citation": "Zhang S., Liu Y., Ye Y., et al. Bee venom therapy: potential mechanisms and therapeutic applications. Toxicon. 2018;148:64\u201373. doi: 10.1016/j.toxicon.2018.04.012.", "ArticleIdList": ["10.1016/j.toxicon.2018.04.012", "29654868"]}, {"Citation": "Hwang J. H., Kim K.-H. Bee venom acupuncture for circumscribed morphea in a patient with systemic sclerosis: a case report. Medicine. 2018;97(49):p. e13404. doi: 10.1097/MD.0000000000013404.", "ArticleIdList": ["10.1097/MD.0000000000013404", "PMC6310600", "30544415"]}, {"Citation": "Tourkina E., Gooz P., Oates J. C., Ludwicka-Bradley A., Silver R. M., Hoffman S. Curcumin-induced apoptosis in scleroderma lung fibroblasts. American Journal of Respiratory Cell and Molecular Biology. 2004;31(1):28\u201335. doi: 10.1165/rcmb.2003-0354OC.", "ArticleIdList": ["10.1165/rcmb.2003-0354OC", "14742295"]}, {"Citation": "Busch C., Jacob C., Anwar A., et al. Diallylpolysulfides induce growth arrest and apoptosis. International Journal of Oncology. 2010;36(3):743\u2013749. doi: 10.3892/ijo_00000550.", "ArticleIdList": ["10.3892/ijo_00000550", "20126995"]}, {"Citation": "Marut W., Jamier V., Kavian N., et al. The natural organosulfur compound dipropyltetrasulfide prevents HOCl-induced systemic sclerosis in the mouse. Arthritis Research & Therapy. 2013;15(5):p. R167. doi: 10.1186/ar4351.", "ArticleIdList": ["10.1186/ar4351", "PMC3979139", "24286210"]}, {"Citation": "Liu J., Yin F., Zheng X., Jing J., Hu Y. Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway. Neurochemistry International. 2007;51(6-7):361\u2013369. doi: 10.1016/j.neuint.2007.04.021.", "ArticleIdList": ["10.1016/j.neuint.2007.04.021", "17629357"]}, {"Citation": "Qi Q., Mao Y., Tian Y., et al. Geniposide inhibited endothelial-mesenchymal transition via the mTOR signaling pathway in a bleomycin-induced scleroderma mouse model. American Journal of Translational Research. 2017;9(3):1025\u20131036.", "ArticleIdList": ["PMC5375995", "28386330"]}, {"Citation": "Hasegawa M., Matsushita Y., Horikawa M., et al. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis. Arthritis & Rheumatism. 2009;60(11):3465\u20133475. doi: 10.1002/art.24934.", "ArticleIdList": ["10.1002/art.24934", "19877032"]}, {"Citation": "Tzen J. T. C., Jinn T. R., Chen Y. C., et al. Magnesium lithospermate B possesses inhibitory activity on Na+,K+-ATPase and neuroprotective effects against ischemic stroke. Acta Pharmacologica Sinica. 2007;28(5):609\u2013615. doi: 10.1111/j.1745-7254.2007.00544.x.", "ArticleIdList": ["10.1111/j.1745-7254.2007.00544.x", "17439716"]}, {"Citation": "Shigematsu T., Tajima S., Nishikawa T., Murad S., Pinnell S. R., Nishioka I. Inhibition of collagen hydroxylation by lithospermic acid magnesium salt, a novel compound isolated from Salviae miltiorrhizae Radix. Biochimica et Biophysica Acta (BBA)-General Subjects. 1994;1200(1):79\u201383. doi: 10.1016/0304-4165(94)90030-2.", "ArticleIdList": ["10.1016/0304-4165(94)90030-2", "8186237"]}, {"Citation": "Alzohairy M. A. Therapeutics role of Azadirachta indica (Neem) and their active constituents in diseases prevention and treatment. Evidence-based Complementary and Alternative Medicine. 2016;2016:11. doi: 10.1155/2016/7382506.7382506", "ArticleIdList": ["10.1155/2016/7382506", "PMC4791507", "27034694"]}, {"Citation": "Diddi S., Bale S., Pulivendala G., Godugu C. Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma. Inflammopharmacology. 2019;27(1):139\u2013149. doi: 10.1007/s10787-018-0527-4.", "ArticleIdList": ["10.1007/s10787-018-0527-4", "30218238"]}, {"Citation": "Izaka K. I., Yamada M., Kawano T., Suyama T. Gastrointestinal absorption and anti-inflammatory effect of bromelain. Japanese Journal of Pharmacology. 1972;22(4):519\u2013534. doi: 10.1016/S0021-5198(19)31648-8.", "ArticleIdList": ["10.1016/S0021-5198(19)31648-8", "4539505"]}, {"Citation": "Pierce H. E., Jr. Pineapple proteases in the treatment of scleroderma: a case report. Journal of the National Medical Association. 1964;56(3):p. 272.", "ArticleIdList": ["PMC2610802", "14143037"]}, {"Citation": "Chen W., Tang F., Xie B., Chen S., Huang H., Liu P. Amelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stress. European Journal of Pharmacology. 2012;674(2-3):359\u2013364. doi: 10.1016/j.ejphar.2011.10.040.", "ArticleIdList": ["10.1016/j.ejphar.2011.10.040", "22088276"]}, {"Citation": "Liu Q.-S., Zhu X. C., Li J. A., et al. Effects of danshen injection on the proliferation of rheumatoid arthritis fibroblast-like synoviocytes cultured with human serum. Zhongguo Zhong xi yi Jie he za Zhi Zhongguo Zhongxiyi Jiehe Zazhi= Chinese Journal of Integrated Traditional and Western Medicine. 2013;33(5):674\u2013678.", "ArticleIdList": ["23905390"]}, {"Citation": "Liu M., Yang J., Li M. Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway. Clinics. 2015;70(4):250\u2013256. doi: 10.6061/clinics/2015(04)06.", "ArticleIdList": ["10.6061/clinics/2015(04)06", "PMC4418395", "26017791"]}, {"Citation": "Singh G., Sharma P. K., Dudhe R., Singh S. Biological activities of Withania somnifera. Annals of Biological Research. 2010;1(3):56\u201363."}, {"Citation": "Bale S., Pulivendala G., Godugu C. Withaferin a attenuates bleomycin-induced scleroderma by targeting FoxO3a and NF-\u03ba\u03b2 signaling: connecting fibrosis and inflammation. BioFactors. 2018;44(6):507\u2013517. doi: 10.1002/biof.1446.", "ArticleIdList": ["10.1002/biof.1446", "30367690"]}, {"Citation": "Stern E. P., Denton C. P. The pathogenesis of systemic sclerosis. Rheumatic Disease Clinics of North America. 2015;41(3):367\u2013382. doi: 10.1016/j.rdc.2015.04.002.", "ArticleIdList": ["10.1016/j.rdc.2015.04.002", "26210124"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "29"}, {"Year": "2021", "Month": "5", "Day": "27"}, {"Year": "2021", "Month": "6", "Day": "8"}, {"Year": "2021", "Month": "7", "Day": "14", "Hour": "7", "Minute": "9"}, {"Year": "2021", "Month": "7", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["34258301", "PMC8253639", "10.1155/2021/9920416"]}}], "PubmedBookArticle": []}